Annual Report

Overview

The report describes the FY2021 launch of VIRALEZE™ in the UK/Europe, registrations in Europe and India, and antiviral testing against SARS-CoV-2 variants. It highlights continued progress in three phase 2 DEP® products and new partnerships with MSD and Chase Sun. Its ESG section reports around 50 employees, 47% female workforce representation, and 40% female Board representation at 30 June 2021.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2021
Period: 1 July 2020 – 30 June 2021
Publication date: 26 August 2021
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services